Literature DB >> 18334760

Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells.

Carmela Matrone1, Anna Di Luzio, Giovanni Meli, Simona D'Aguanno, Cinzia Severini, Maria Teresa Ciotti, Antonino Cattaneo, Pietro Calissano.   

Abstract

Nerve growth factor (NGF) exerts a trophic, antiapoptotic action on several neuronal targets, including the clonal cell line PC12. In the current study, we demonstrate that withdrawal of this neurotrophin from PC12 differentiated cells causes overproduction of amyloid-beta (Abeta) peptides, which are the most toxic protein fragments directly implicated in the development of Alzheimer disease (AD), concomitantly with cell death by apoptosis. Abeta production and apoptotic death, occurring after withdrawal from NGF-differentiated PC12 cells, are completely inhibited by beta- and gamma-secretase inhibitors and by antibodies directed against Abeta peptides, favouring maintenance of PC12 morphology and neuritic network. These peptides are partially released and largely deposited as aggregates only soluble with strong detergent treatment generally employed to dissolve senile plaques. Furthermore, partial silencing of APP mRNA, by siRNA, reduces not only the extent of Abeta production but also apoptotic death. Abeta production and apoptosis are also induced in differentiated PC12 cells by kinase inhibitors of Trk-A, the high affinity receptor of NGF and, in this case, the co-incubation with beta- and gamma-secretase inhibitors totally revert apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334760     DOI: 10.3233/jad-2008-13109

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  29 in total

1.  NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons.

Authors:  Carmela Matrone; Maria Teresa Ciotti; Delio Mercanti; Roberta Marolda; Pietro Calissano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

2.  Improvement of cerebral function by anti-amyloid precursor protein antibody infusion after traumatic brain injury in rats.

Authors:  Tatsuki Itoh; Takao Satou; Shozo Nishida; Masahiro Tsubaki; Shigeo Hashimoto; Hiroyuki Ito
Journal:  Mol Cell Biochem       Date:  2009-01-07       Impact factor: 3.396

Review 3.  Genetic determinants at the interface of cancer and neurodegenerative disease.

Authors:  L G T Morris; S Veeriah; T A Chan
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

4.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

5.  C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively.

Authors:  Huiping Xie; Zhimin Xiao; Jian Huang
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

6.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

7.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.

Authors:  Anatoly Nikolaev; Todd McLaughlin; Dennis D M O'Leary; Marc Tessier-Lavigne
Journal:  Nature       Date:  2009-02-19       Impact factor: 49.962

Review 8.  Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease.

Authors:  Lian-Feng Lin; Min-Jing Liao; Xiao-Yan Xue; Wei Zhang; Li Yan; Liang Cai; Xiao-Wen Zhou; Xing Zhou; Huan-Min Luo
Journal:  Neurosci Bull       Date:  2012-11-21       Impact factor: 5.203

Review 9.  Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis.

Authors:  Antonino Cattaneo; Pietro Calissano
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

10.  Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated phosphorylation.

Authors:  C Matrone; R Marolda; S Ciafrè; M T Ciotti; D Mercanti; P Calissano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.